Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Jan 21, 2021

BUY
$3.99 - $5.7 $2,394 - $3,420
600 Added 600.0%
700 $0
Q3 2020

Oct 27, 2020

SELL
$4.38 - $6.43 $2,628 - $3,858
-600 Reduced 85.71%
100 $0
Q2 2020

Jul 22, 2020

SELL
$3.0 - $6.9 $1,200 - $2,760
-400 Reduced 36.36%
700 $0
Q1 2020

May 07, 2020

BUY
$2.36 - $9.86 $2,596 - $10,846
1,100 New
1,100 $0
Q1 2019

May 10, 2019

SELL
$2.62 - $4.44 $2,882 - $4,884
-1,100 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$3.85 - $7.35 $4,235 - $8,085
1,100 New
1,100 $2,000
Q4 2017

Jan 17, 2018

SELL
$3.4 - $4.15 $17,000 - $20,750
-5,000 Closed
0 $0
Q3 2017

Oct 17, 2017

BUY
$3.55 - $5.25 $17,750 - $26,250
5,000
5,000 $0

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.